These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26253710)

  • 1. Seasonal variations in vitamin D in relation to growth in short prepubertal children before and during first year growth hormone treatment.
    Andersson B; Swolin-Eide D; Kriström B; Gelander L; Magnusson P; Albertsson-Wikland K
    J Endocrinol Invest; 2015 Dec; 38(12):1309-17. PubMed ID: 26253710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D status and response to growth hormone treatment in prepubertal children with growth hormone deficiency.
    Durá-Travé T; Gallinas-Victoriano F; Moreno-González P; Urretavizcaya-Martinez M; Berrade-Zubiri S; Chueca-Guindulain MJ
    J Endocrinol Invest; 2020 Oct; 43(10):1485-1492. PubMed ID: 32215862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term changes in bone formation markers following growth hormone (GH) treatment in short prepubertal children with a broad range of GH secretion.
    Andersson B; Swolin-Eide D; Magnusson P; Albertsson-Wikland K
    Clin Endocrinol (Oxf); 2015 Jan; 82(1):91-9. PubMed ID: 24818653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.
    Lundberg E; Kriström B; Jonsson B; Albertsson-Wikland K;
    BMC Endocr Disord; 2015 Dec; 15():84. PubMed ID: 26682747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of insulin-like binding protein-2 in prepubertal short children and its diagnostic value in the evaluation of growth hormone deficiency.
    van Doorn J; Ringeling AM; Rikken B; van Buul-Offers SC
    Horm Res; 2001; 55(3):147-54. PubMed ID: 11549877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D status in prepubertal children with isolated idiopathic growth hormone deficiency: effect of growth hormone therapy.
    Hamza RT; Hamed AI; Sallam MT
    J Investig Med; 2018 Jun; 66(5):1-8. PubMed ID: 29478008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of exogenous and endogenous growth hormone on plasma growth hormone binding activity in prepubertal children.
    Zadik Z; Amnon Z; Altman Y; Chen M
    Horm Res; 1993; 40(5-6):161-7. PubMed ID: 8112715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
    Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children?
    Lanes R; Jakubowicz S
    J Pediatr; 2002 Nov; 141(5):606-10. PubMed ID: 12410186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in the oxidant-antioxidant status in prepubertal children with growth hormone deficiency: effect of growth hormone replacement therapy.
    Mohn A; Marzio D; Giannini C; Capanna R; Marcovecchio M; Chiarelli F
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):537-42. PubMed ID: 16268806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D in children with growth hormone deficiency due to pituitary stalk interruption syndrome.
    Delecroix C; Brauner R; Souberbielle JC
    BMC Pediatr; 2018 Jan; 18(1):11. PubMed ID: 29368588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seasonality of growth response to GH therapy in prepubertal children with idiopathic growth hormone deficiency.
    Land C; Blum WF; Stabrey A; Schoenau E
    Eur J Endocrinol; 2005 May; 152(5):727-33. PubMed ID: 15879358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and chronic effects of subcutaneous growth hormone (GH) injections on plasma levels of GH binding protein in short children.
    Bjarnason R; Albertsson-Wikland K; Carlsson LM
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2756-60. PubMed ID: 7673420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study.
    Cohen P; Rogol AD; Howard CP; Bright GM; Kappelgaard AM; Rosenfeld RG;
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2480-6. PubMed ID: 17356043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
    Esposito V; Di Biase S; Lettiero T; Labella D; Simeone R; Salerno M
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
    Hokken-Koelega AC; Stijnen T; De Jong MC; Donckerwolcke RA; De Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.